6505--Benazepril Hydrochloride (HCL) Tablets

The Department of Veterans Affairs National Acquisition Center is soliciting offers for the supply of Benazepril Hydrochloride (HCL) tablets in four strengths (5mg, 10mg, 20mg, and 40mg) and two package sizes (100 and 500 tablet bottles) for a single award across eight line items. The solicitation requires offerors to provide firm fixed pricing that includes a 0.5% Cost Recovery Fee and must not exceed two decimal places. Key qualifications include FDA approval certification, current Good Manufacturing Practice (cGMP) compliance documentation for all manufacturing facilities, and a unique 11-digit National Drug Code (NDC) number for each offered product. Non-manufacturer offerors must submit a Letter of Commitment from the manufacturer. The offer due date is May 19, 2026, at 2:30 PM Central Time, with contract implementation not to exceed 60 days following award.

This is an unrestricted solicitation with no set-aside designation, and no incumbent contractor information has been disclosed. Total estimated annual requirements range from 947 to 8,650 bottles depending on the specific line item, with the products distributed to the Department of Veterans Affairs, Department of Defense, Indian Health Service, Bureau of Prisons, Federal Health Care Centers, and participating State Veteran Homes through Government Prime Vendor programs. The contract will operate on a firm fixed-price basis with an ordering period of one year plus four optional one-year periods. Contractors exceeding $900,000 in contract value must submit subcontracting plans with minimum goals for service-disabled veteran-owned and veteran-owned small business participation. Contractors must establish and maintain business-to-business agreements with Prime Vendor contractors and submit quarterly sales reports with Cost Recovery Fee payments.